4506 On Other Exchanges
Symbol
Exchange
4506 is not on other exchanges.

Executive Profile*

Chiang J. Li M.D., FACP

AgeTotal Calculated CompensationThis person is connected to 22 board members in 2 different organizations across 5 different industries.

See Board Relationships
51--

Background*

Dr. Chiang J. Li, M.D., FACP., Founded Boston Biomedical, Inc. in November 2006. Dr. Li is the Founder of Cequent Pharmaceuticals, Inc. He served as the President, Chief Executive Officer and Chief Medical Officer at Boston Biomedical, Inc. (BBI) until April 24, 2017. Dr. Li served as an Executive Officer and Head of Global Oncology of Sumitomo Dainippon Pharma Co., Ltd until April 4, 2017. He served as Head of Global Oncology at the DSP Group. Dr. Li served as the Chief ...

Read Full Background

Corporate Headquarters*

6-8 Doshomachi 2-chome
Osaka, -- 541-0045

Japan

Phone: 81 6 6203 5321
Fax: 81 6 6202 6028

Board Members Memberships*

Founder, Chairman of the Scientific Advisory Board and Director

Education*

MD
Harvard Medical School
Unknown/Other Education
Harvard-MIT Division of Health Sciences and Technology

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SUMITOMO DAINIPPON PHARMA CO, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.